vs
Side-by-side financial comparison of FGI Industries Ltd. (FGI) and Sanara MedTech Inc. (SMTI). Click either name above to swap in a different company.
FGI Industries Ltd. is the larger business by last-quarter revenue ($30.5M vs $27.5M, roughly 1.1× Sanara MedTech Inc.). Sanara MedTech Inc. runs the higher net margin — -5.9% vs -8.6%, a 2.8% gap on every dollar of revenue. On growth, Sanara MedTech Inc. posted the faster year-over-year revenue change (4.6% vs -14.4%). Sanara MedTech Inc. produced more free cash flow last quarter ($3.9M vs $2.3M). Over the past eight quarters, Sanara MedTech Inc.'s revenue compounded faster (21.8% CAGR vs -0.5%).
FGI Industries Ltd is a global designer, manufacturer and distributor of kitchen and bath products, home organization solutions, and home improvement goods. It serves major retail chains, home specialty stores and e-commerce platforms across North America, Europe and the Asia-Pacific region.
Sanara MedTech Inc. is a US-based medical technology company that develops, manufactures, and distributes innovative surgical, wound care, and post-acute rehabilitation products. It mainly serves healthcare providers, hospitals, and long-term care facilities across North America, with a portfolio of FDA-cleared solutions designed to improve patient outcomes and lower clinical care operational costs.
FGI vs SMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $30.5M | $27.5M |
| Net Profit | $-2.6M | $-1.6M |
| Gross Margin | 26.7% | 93.2% |
| Operating Margin | -2.2% | 23.5% |
| Net Margin | -8.6% | -5.9% |
| Revenue YoY | -14.4% | 4.6% |
| Net Profit YoY | -553.1% | 5.3% |
| EPS (diluted) | $-1.63 | $-0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.5M | $27.5M | ||
| Q3 25 | $35.8M | $26.3M | ||
| Q2 25 | $31.0M | $25.8M | ||
| Q1 25 | $33.2M | $23.4M | ||
| Q4 24 | $35.6M | $26.3M | ||
| Q3 24 | $36.1M | $21.7M | ||
| Q2 24 | $29.4M | $20.2M | ||
| Q1 24 | $30.8M | $18.5M |
| Q4 25 | $-2.6M | $-1.6M | ||
| Q3 25 | $-1.7M | $-30.4M | ||
| Q2 25 | $-1.2M | $-2.0M | ||
| Q1 25 | $-629.1K | $-3.5M | ||
| Q4 24 | $-402.3K | $-1.7M | ||
| Q3 24 | $-550.1K | $-2.9M | ||
| Q2 24 | $163.6K | $-3.5M | ||
| Q1 24 | $-412.2K | $-1.8M |
| Q4 25 | 26.7% | 93.2% | ||
| Q3 25 | 26.5% | 92.9% | ||
| Q2 25 | 28.1% | 92.5% | ||
| Q1 25 | 26.8% | 92.2% | ||
| Q4 24 | 24.6% | 91.4% | ||
| Q3 24 | 25.8% | 90.8% | ||
| Q2 24 | 30.5% | 90.0% | ||
| Q1 24 | 27.4% | 89.8% |
| Q4 25 | -2.2% | 23.5% | ||
| Q3 25 | 1.0% | 11.2% | ||
| Q2 25 | -2.7% | -0.1% | ||
| Q1 25 | -3.9% | -8.9% | ||
| Q4 24 | -3.5% | 18.6% | ||
| Q3 24 | -0.2% | 3.6% | ||
| Q2 24 | -1.5% | -14.3% | ||
| Q1 24 | -1.0% | -8.3% |
| Q4 25 | -8.6% | -5.9% | ||
| Q3 25 | -4.6% | -115.5% | ||
| Q2 25 | -4.0% | -7.8% | ||
| Q1 25 | -1.9% | -15.1% | ||
| Q4 24 | -1.1% | -6.5% | ||
| Q3 24 | -1.5% | -13.2% | ||
| Q2 24 | 0.6% | -17.4% | ||
| Q1 24 | -1.3% | -9.5% |
| Q4 25 | $-1.63 | $-0.32 | ||
| Q3 25 | $-0.86 | $-3.40 | ||
| Q2 25 | $-0.64 | $-0.23 | ||
| Q1 25 | $-0.07 | $-0.41 | ||
| Q4 24 | $-0.38 | $-0.18 | ||
| Q3 24 | $-0.29 | $-0.34 | ||
| Q2 24 | $0.08 | $-0.41 | ||
| Q1 24 | $-0.04 | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9M | $16.6M |
| Total DebtLower is stronger | — | $46.0M |
| Stockholders' EquityBook value | $17.3M | $5.9M |
| Total Assets | $69.5M | $72.9M |
| Debt / EquityLower = less leverage | — | 7.74× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.9M | $16.6M | ||
| Q3 25 | $1.9M | $14.9M | ||
| Q2 25 | $2.5M | $17.0M | ||
| Q1 25 | $1.2M | $20.7M | ||
| Q4 24 | $4.6M | $15.9M | ||
| Q3 24 | $3.0M | $16.3M | ||
| Q2 24 | $1.3M | $6.2M | ||
| Q1 24 | $3.3M | $2.8M |
| Q4 25 | — | $46.0M | ||
| Q3 25 | — | $45.1M | ||
| Q2 25 | — | $44.2M | ||
| Q1 25 | — | $43.4M | ||
| Q4 24 | — | $30.7M | ||
| Q3 24 | — | $30.1M | ||
| Q2 24 | — | $14.4M | ||
| Q1 24 | — | $9.7M |
| Q4 25 | $17.3M | $5.9M | ||
| Q3 25 | $19.7M | $6.1M | ||
| Q2 25 | $21.3M | $35.4M | ||
| Q1 25 | $21.8M | $36.7M | ||
| Q4 24 | $22.3M | $39.4M | ||
| Q3 24 | $23.5M | $39.8M | ||
| Q2 24 | $23.8M | $41.7M | ||
| Q1 24 | $23.9M | $43.3M |
| Q4 25 | $69.5M | $72.9M | ||
| Q3 25 | $73.0M | $71.1M | ||
| Q2 25 | $71.7M | $98.8M | ||
| Q1 25 | $68.5M | $96.4M | ||
| Q4 24 | $75.5M | $88.1M | ||
| Q3 24 | $74.7M | $88.5M | ||
| Q2 24 | $69.9M | $73.4M | ||
| Q1 24 | $68.6M | $70.9M |
| Q4 25 | — | 7.74× | ||
| Q3 25 | — | 7.33× | ||
| Q2 25 | — | 1.25× | ||
| Q1 25 | — | 1.18× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | 0.76× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.22× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $2.3M | $3.9M |
| Free Cash FlowOCF − Capex | $2.3M | $3.9M |
| FCF MarginFCF / Revenue | 7.5% | 14.0% |
| Capex IntensityCapex / Revenue | 0.2% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-212.5K | $2.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.3M | $3.9M | ||
| Q3 25 | $-1.9M | $2.2M | ||
| Q2 25 | $7.6M | $2.7M | ||
| Q1 25 | $-7.4M | $-2.0M | ||
| Q4 24 | $617.4K | $932.0K | ||
| Q3 24 | $-915.0K | $2.1M | ||
| Q2 24 | $862.1K | $-1.4M | ||
| Q1 24 | $-8.0M | $-1.6M |
| Q4 25 | $2.3M | $3.9M | ||
| Q3 25 | $-2.1M | $1.1M | ||
| Q2 25 | $7.4M | $902.7K | ||
| Q1 25 | $-7.7M | $-3.7M | ||
| Q4 24 | $-214.1K | $859.9K | ||
| Q3 24 | $-1.1M | $2.0M | ||
| Q2 24 | $281.5K | $-1.5M | ||
| Q1 24 | $-8.6M | $-1.7M |
| Q4 25 | 7.5% | 14.0% | ||
| Q3 25 | -5.9% | 4.2% | ||
| Q2 25 | 23.8% | 3.5% | ||
| Q1 25 | -23.3% | -15.9% | ||
| Q4 24 | -0.6% | 3.3% | ||
| Q3 24 | -3.0% | 9.4% | ||
| Q2 24 | 1.0% | -7.3% | ||
| Q1 24 | -28.0% | -9.0% |
| Q4 25 | 0.2% | 0.3% | ||
| Q3 25 | 0.7% | 4.0% | ||
| Q2 25 | 0.7% | 6.8% | ||
| Q1 25 | 1.1% | 7.4% | ||
| Q4 24 | 2.3% | 0.3% | ||
| Q3 24 | 0.5% | 0.0% | ||
| Q2 24 | 2.0% | 0.3% | ||
| Q1 24 | 2.0% | 0.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.27× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FGI
| Sanitaryware | $19.1M | 63% |
| Shower System | $5.8M | 19% |
| Kitchen And Bath Other | $3.3M | 11% |
| Bath Furniture Products | $2.3M | 7% |
SMTI
| Soft Tissue Repair Products | $24.7M | 90% |
| Bone Fusion Products | $2.8M | 10% |